Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta alethine in low-grade B-cell lymphoma
NCT00007839Phase 2Unknown
- Sponsor
- LifeTime Pharmaceuticals, Inc.
- Start
- Aug 2000
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of beta-alanine in B cell lymphoma, sponsored by LifeTime Pharmaceuticals, Inc. Primary endpoints: Antitumor effects and Safety and adverse events. Status: unknown.
02
Drugs
beta-alanine
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT00007839.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00007839.